Table 3.
Odds ratio for left ventricular hypertrophy by sST2
| sST2(mg/ml) | Odds ratio(95% confidence interval) | ||||
|---|---|---|---|---|---|
| LVH, n% | Non-LVH, n% | Crude | Model 1 | Model 2 | |
| Tertile 1 (<12.6) |
25 (15.53%) |
136 (84.47%) |
Reference | Reference | Reference |
| Tertile 2 [12.6–18.7] |
38 (23.46%) |
124 (76.54%) |
1.67 (0.95–2.92) |
1.88 (1.05–3.36) |
1.83 (0.99–3.36) |
| Tertile 3 (≥ 18.8) |
85 (53.13%) |
75 (46.88%) |
6.17 (3.64–10.45) |
6.99 (3.99–12.27) |
6.61 (3.66–11.95) |
| P for trend | P < 0.001 | P < 0.001 | P < 0.001 | ||
| sST2 (per SD increase) | 3.71 (2.73–5.04) |
4.10 (2.94–5.74) |
4.20 (2.93–6.04) |
||
Model 1: adjusted for age, sex, BMI.
Model 2: multivariate stepwise logistic regression adjusted for age, sex, BMI, diabetes, HbA1c, creatinine, triglyceride, systolic pressure, pulse pressure, Hypertension Grade and Duration.
Abbreviations: LVH, left ventricular hypertrophy; SD, standard deviation; sST2, soluble stimulating factor 2.